8-K/A XBRL

8-K/A Filing

Company: Calidi Biotherapeutics, Inc.
Filed: February 10, 2025
Period of Report: February 10, 2025
Accession Number: 0001493152-25-005699

View Document ↗ View on SEC.gov ↗